← Leaderboards
Arthur C Theodore
Boston University Medical Campus
$379,548
Attributed
$379,548
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $10.3K · FY2005–06$20K$15K$10K$5K$0
'05
'06
Funding mix
By agency
NIH$379,548 · 3
By mechanism
U01$343,122 · 1
M01$36,426 · 2
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Robert A Lafyatis$10,905,922
- Maria Trojanowska$16,742,564
- Mary C Williams$2,637,900
- Peter F Weller$19,827,145
- Andreea Monica Bujor$2,459,323
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeLongitudinal Human StudyClinical ResearchPulmonary Fibrosis /GranulomaCyclophosphamideSystemic SclerodermaRespiratory Disorder ChemotherapyDrug Screening /EvaluationDyspneasFunctional AbilityHuman SubjectHuman Therapy EvaluationInflammationCooperative StudyDiagnostic Respiratory LavageLung AlveolusRespiratory Airway VolumePatient Oriented ResearchPlacebosMedical ComplicationCarbon Dioxide TensionClinical TrialsDisease /Disorder Prevention /ControlRespiratory Function
Grant awards (7)
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SYSTEMIC SCLEROSIS PULMONARY ALVEOLITIS$1,158
M01 · FY2006 · RR · contact PI
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SYSTEMIC SCLEROSIS PULMONARY ALVEOLITIS$10,313
M01 · FY2005 · RR
Oral Cyclophosphamide/Placebo in SSC Pulmonary Alveoliti$24,955
M01 · FY2004 · RR
SCLERODERMA LUNG STUDY$65,348
U01 · FY2003 · HL
SCLERODERMA LUNG STUDY$86,565
U01 · FY2002 · HL
SCLERODERMA LUNG STUDY$102,993
U01 · FY2001 · HL
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SSC ALVEOLITIS$88,216
U01 · FY2000 · HL